This work develops an antibody uptake assay for imaging intra-lineage Notch/DeltaD signaling in dividing radial glia progenitors of the embryonic zebrafish brain.
Asymmetric cell division (ACD), which produces two daughter cells of different fates, is fundamental for generating cellular diversity. In the developing organs of both invertebrates and vertebrates, asymmetrically dividing progenitors generates a Notchhi self-renewing and a Notchlo differentiating daughter. In the embryonic zebrafish brain, radial glia progenitors (RGPs)-the principal vertebrate neural stem cells-mostly undergo ACD to give birth to one RGP and one differentiating neuron. The optical clarity and easy accessibility of zebrafish embryos make them ideal for in vivo time-lapse imaging to directly visualize how and when the asymmetry of Notch signaling is established during ACD. Recent studies have shown that dynamic endocytosis of the Notch ligand DeltaD plays a crucial role in cell fate determination during ACD, and the process is regulated by the evolutionarily conserved polarity regulator Par-3 (also known as Pard3) and the dynein motor complex. To visualize the in vivo trafficking patterns of Notch signaling endosomes in mitotic RGPs, we have developed this antibody uptake assay. Using the assay, we have uncovered the dynamicity of DeltaD-containing endosomes during RGP division.
Notch signaling controls cell fate decision and patterning during development in metazoans1, and recent studies have shown that Notch signaling in stem cell division mainly depends on endocytic trafficking2,3. Endocytosed Notch/Delta can activate Notch signaling in the nucleus and enhance the transcription of Notch target genes4,5,6. Directional Notch/Delta endosomal trafficking was first observed in Drosophila sensory organ precursor (SOP) cells during its asymmetric cell division (ACD), resulting in a higher Notch signaling activity in pIIa than in pIIb7,8. Antibody uptake assays with anti-Delta and anti-Notch antibodies have been applied to monitor the endocytic process in mitotic SOP cells. Notch/DeltaD endosomes move along with a kinesin motor protein to the central spindle during cytokinesis, and are asymmetrically translocated into the pIIa cell due to the antiparallel array of the asymmetric central spindle at the last moment of cell division3,8. These studies have shed light on the molecular mechanisms regulating asymmetric division in Drosophila SOP cells, but it is unclear whether similar endocytic processes occur in vertebrate radial glia progenitors (RGPs).
Moreover, the molecular mechanisms that regulate asymmetric Notch/DeltaD signaling during vertebrate RGP division are not well understood. In zebrafish, it has been reported that the interaction of Notch and Delta facilitates the endocytosis of the DeltaD ligand9. It is unknown whether DeltaD endocytosis can impact the cell fate choice of daughter cells in the developing vertebrate brain. Recent studies show injecting fluorescently conjugated anti-DeltaD antibodies into the neural tube could label Sara endosomes specifically in neuroepithelial cells, and anti-DeltaD containing Sara endosomes preferentially segregate into proliferating daughter cells10. It has been suggested that Notch signaling from the endosomes could regulate daughter cell fate. Previous results have shown that most zebrafish RGP cells in the developing forebrain undergo ACD, and the daughter cell fate determination is dependent on intralineage Notch/DeltaD signaling11. In order to elucidate the nature of the intralineage Notch/DeltaD signaling in zebrafish RGPs, we have developed the anti-DeltaD antibody uptake assay in the zebrafish developing brain. Using this protocol, we have successfully performed live labeling and imaging of DeltaD endocytic trafficking in mitotic RGPs.
The fluorescently labeled anti-DeltaD-antibody is efficiently internalized into the RGPs along the forebrain ventricle. It has greatly facilitated the discovery of directional trafficking of DeltaD endosomes in the asymmetrically dividing RGPs12,13. Compared to previous antibody uptake protocols developed for Drosophila notum cultures and the zebrafish spinal cord10, this protocol has achieved long-lasting and highly efficient anti-DeltaD labeling in the brain ventricle cell layer, specifically with less than 10 nL of microinjected antibody mixture. The hindbrain ventricle injection is very convenient for applying the antibody uptake assay in the developing brain, as the hindbrain ventricle is well expanded in zebrafish embryos and filled up with cerebrospinal fluid at early development stage14. By injecting the antibody mixture into the hindbrain ventricle without injuring any crucial developing tissues, the protocol has minimized possible damage to the imaging zone in the forebrain as much as possible. The reduced dosage of the injected primary antibody has also avoided potential side-effects of interfering with endogenous Delta-Notch signaling in vivo. This protocol can be easily combined with other pharmacological or genetic perturbations, utilized at different developmental stages, and possibly adapted to the adult brain as well as human pluripotent stem cell-derived 2D/3D brain organoids. Taken together, the protocol has made it possible to understand how and when Notch signaling asymmetry is established during ACD. The main challenge for successful implementation of this protocol is to achieve precise delivery of appropriate concentrations of the antibody based on specific experimental conditions.
We have used the AB wild type line and transgenic line Tg [ef1a:Myr-Tdtomato] for the study. All animal experiments were approved by the Institutional Animal Care and Use Committee (IACUC) at the University of California, San Francisco, USA (Approval Number: AN179000).
1. Preparation of zebrafish embryos
2. Preparation of microinjection
3. Microinjection
4. Mounting and time-lapse live imaging
In Figure 2A, the embryos injected with Atto647N, without binding with the primary antibody, showed background fluorescence in the brain ventricle. Very few engulfed fluorescent particles can be observed in the cells. The anti-Dld-Atto647N injected zebrafish embryos showed large amounts of internalized fluorescent particles in most cells of the developing forebrain (Figure 2A, right panel). After zooming in to focus on mitotic RGPs, as shown in Figure 2B, we were able to record the dynamic movement of intracellular anti-Dld-Atto647N endosomes during cell division (Video 1). Most mitotic RGPs showed anterior or posterior asymmetric segregation of anti-Dld-Atto647N endosomes into two daughter cells12. We also noticed that the asymmetry became stabilized toward the end of anaphase, resulting in asymmetric inheritance of Notch signaling endosomes by the daughter cells afterward12.
Figure 1: Flowchart of experimental steps. Transgenic zebrafish expressing the MyR-Tdtomato reporter are outcrossed with AB wild-type on day 1. On day 2, red fluorescent embryos are selected for microinjection, followed by time-lapsing imaging. The whole experiment on the 2nd day takes about 8 h. Please click here to view a larger version of this figure.
Figure 2: Time-lapse imaging of anti-Dld-Atto-647N antibody uptake in the developing zebrafish brain. (A) Anti-Dld-Atto-647N uptake after 30 min of microinjection in the forebrain of a 1 day post-fertilization (dpf) embryo. On the left panel is the embryo injected with Atto-647N only. On the right panel is the embryo injected with anti-Dld-Atto-647N. Dash lines indicate the apical layer along the ventricle. The rectangle zone is shown in high magnification in B. Scale bar = 40 µm. Abbreviations: Di = Diencephalon; Tel = Telencephalon; Ve = Ventricle. (B) Time-lapse imaging panels of anti-Dld-Atto-647N dynamics during mitosis. The eight timeframes in the montage covered the entire mitotic cycle, depicting the uptake and segregation of anti-Dld-Atto-647N into two daughter cells of a dividing RGP. Scale bar = 5 µm The cell membrane is outlined. In both A and B, MyR-Tdtomato labeling on the membrane is blue, and anti-Dld-Atto-647N is magenta. Please click here to view a larger version of this figure.
Video 1: Dynamics of internalized anti-Dld-Atto-647N in dividing radial glia cells throughout mitosis (40 timeframes and an interval time of 30 s between each frame; 20 min in total). Please click here to download this Video.
We have developed an antibody uptake assay for labeling and imaging endosomal Notch/Delta trafficking in zebrafish radial glia progenitors with high efficiency. Compared to previous methods used for tracking labeled anti-DeltaD antibody in Drosophila SOP cells7,8, our method used microinjection instead of incubation of samples in the conjugated antibody. Fluorescently conjugated anti-Dld antibodies were microinjected into the hindbrain ventricle; this technique does not cause injury, as evidenced by the normal development and full recovery of embryos after injection. The embryonic ventricles are continuous, allowing the injected antibody to freely disperse toward the forebrain after microinjection. The injected anti-Dld-atto647N lasts for over 24 h as a stable resource of continuous antibody uptake in the brain. Compared to neural tube injection, introduced in a previous report10, the zebrafish hindbrain ventricle injection does not cause tissue injury and enables selective anti-Dld-Atto647N uptake by mitotic RGPs lining the brain ventricles in vivo. Although we have not checked the antibody uptake in neuroepithelial cells in the spinal cord, the anti-Dld-Atto647N antibody uptake should be applicable there, just as in the brain. The conjugated antibodies injected into the hindbrain ventricle are expected to diffuse along the spinal cord as well.
For the successful application of the antibody uptake assay, the most important issue is to use a primary antibody that has high binding affinity and specificity for the extracellular domain of a membrane protein target. In addition to labeling Notch/Delta signaling, the protocol is applicable for labeling other membrane proteins or extracellular proteins by using similar strategies. Our protocol has demonstrated highly efficient anti-Dld antibody uptake in developing zebrafish embryos because of the high quality and high specificity of the anti-Dld primary antibody. Secondly, the conjugation of anti-Dld primary antibody with the fluorescent secondary antibody is critical for achieving a high level of antibody uptake efficiency in vivo. We have found Atto non-bleaching secondary antibodies to be more stable and much brighter than other fluorescent antibodies, such as Zenon and Alexa secondary antibodies used in Drosophila notum cultures7,10. We chose Atto647N as the fluorescent label, as we normally would use it together with GFP or RFP transgenic zebrafish or some other fluorescent markers sharing similar excitation wavelengths as GFP or RFP. Other non-bleachable secondary antibodies with different excitation wavelengths should also work with the protocol. In our protocol, we shortened the incubation time of primary antibodies mixed with the Atto secondary antibody from 12 h to 30 min, and decreased the concentration of Anti-Dld antibodies to 0.05 mg/mL in the final microinjection mixtures. A higher concentration of anti-Dld antibody (0.25 mg/mL) did not increase the antibody uptake efficiency in zebrafish embryos; this may be the reason for needing long incubation times, in order to achieve sufficient labeling with fluorescent secondary antibodies10. We did not use anti-Dld antibody at a higher concentration as in previous studies10, because there is a possibility that injected anti-Dld-Atto647N antibodies compete with the endogenously expressed Notch/Delta when binding DeltaD ligand on the membrane of RGPs, thereby interfering with cis or trans Notch/Delta signaling in vivo. We also found that blocking buffer added after primary antibody conjugation was helpful for increasing the specificity of the antibody uptake assay in vivo. As shown in Figure 2, most RGPs in the forebrain internalize anti-Dld-Atto647N actively. Without adding the blocking buffer, most cells show very few internalized anti-Dld-Atto647N endosomes (data not shown).
The main limitation of the protocol is the availability of the antibodies that can be used for the uptake assay. Our protocol is applicable for labeling membrane expressed proteins, if a good antibody to the extracellular domain is available. For cytosolic and nuclear proteins, the antibody uptake assay is not applicable, as the conjugated antibodies cannot pass through the cell membrane to bind to their intracellular binding targets. Live imaging of intracellular proteins mainly depends on different types of fluorescent transgenic models. In recent decades, more fluorescent dyes have been developed for live-cell imaging, such as the Silicon Rhodamine-like (SiR) technology, which has significantly contributed to the live cell imaging of DNA, RNA, actin, and tubulin17. A combination of different live labeling strategies would be the best way to study complex signaling pathways in live cells.
The authors have nothing to disclose.
The project was supported by NIH R01NS120218, the UCSF Mary Anne Koda-Kimble Seed Award for Innovation, and Chan Zuckerberg Biohub.
35mm glass bottom culture dish | MatTek corporation | P35GC-1.5-10-C | |
air pressure injector | Narishige | IM300 | |
Anti-Mouse-IgG-Atto647N | Sigma-Aldrich | 50185 | |
CaCl2.2H2O | Sigma-Aldrich | C3306 | |
Capillaries, 1.2 mm OD, 0.9 mm ID, with filament | World Precision Instruments | 1B120F-6 | |
CSU-W1 Spinning Disk/High Speed Widefield | Nikin | N/A | Nikon Ti inverted fluorescence microscope with CSU-W1 large field of view confocal. |
Dumont Medical Tweezers Style 5 | Thomas Scientific | 72877-D | |
Flaming-Brown P897 puller | Sutter Instruments | N/A | https://www.sutter.com/manuals/P-97-INT_OpMan.pdf |
KCl | Millipore | 529552 | |
MgSO4.7H2O | Sigma-Aldrich | M2773 | |
micromanipulators | World Precision Instruments | WPI M3301R | |
Mouse anti-Dld | Abcam | AB_1268496 | |
Mouse IgG blocking buffer from Zenon | Thermofisher Scientific | Z25008 | |
NaCl | Sigma-Aldrich | S3014 | |
Phenol red | Sigma-Aldrich | P0290 | |
Stemi 2000 | Zeiss | N/A | |
Tricaine | Sigma-Aldrich | E10521 | |
UltraPureTM low melting point agarose | Invitrogen | 16520050 |